My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Systematic Stock Investing …in less than a minute.
BSE: 524796 | NSE: | Pharmaceuticals & Drugs | Small Cap
1. Is Vardhaman Laboratories Ltd. a good quality company?
Data is not available for this company.
2. Is Vardhaman Laboratories Ltd. undervalued or overvalued?
No data found
3. Is Vardhaman Laboratories Ltd. a good buy now?
No data found
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | TTM | |||
| ROCE % ⓘ | -8.3% | -8.6% | -3.5% | 3.4% | -3.6% | -1% | -1.2% | -1.5% | -1.8% | -2% | - | ||
| Value Creation Index ⓘ | -1.6 | -1.6 | -1.3 | -0.8 | -1.3 | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 0.3 | 0.3 | 1.2 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| YoY Gr. Rt. % | - | -15.6% | 359.3% | -52.4% | -100% | NA | NA | NA | NA | NA | - | ||
| Adj EPS ⓘ | -0.6 | -0.6 | -0.3 | 0.2 | -0.2 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | -217.7% | NA | NA | NA | NA | NA | - | ||
| BVPS (₹) ⓘ | 6.3 | 5.1 | 4.9 | 5.5 | 5.2 | 5.2 | 5.1 | 5 | 4.9 | 4.9 | 4.8 | ||
| Adj Net Profit ⓘ | -0.3 | -0.2 | -0.1 | 0.1 | -0.1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cash Flow from Ops. ⓘ | 0 | -0.1 | 0.4 | -1.8 | -0.1 | 0.1 | 0.3 | 0 | 0 | 0 | - | ||
| Debt/CF from Ops. ⓘ | 37.4 | -3.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | -100% | NA | NA | NA | ||||||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||||||
| BVPS ⓘ | -2.9 | -1.5 | -1.7 | -1.8 | ||||||||
| Share Price | - | - | - | - | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | TTM | ||
| Return on Equity % ⓘ | -9.5 | -9.9 | -6.6 | 3.4 | -3.8 | -1 | -1.2 | -1.5 | -1.8 | -2 | -1.2 | |
| Op. Profit Mgn % ⓘ | -71.8 | -61.5 | 1.3 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit Mgn % ⓘ | -81.9 | -86.1 | -11 | 12.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt to Equity ⓘ | 0.1 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |
| Working Cap Days ⓘ | 1,069 | 1,181 | 328 | 1,147 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash Conv. Cycle ⓘ | 1,035 | 1,102 | 41 | 689 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
No data to display
Return on Equity has declined versus last 3 years average to %
Sales growth has been subdued in last 3 years %
Sales growth is not so good in last 4 quarters at %
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | -0.1 | - |
| TTM Sales (₹ Cr.) | 0 | - |
| BVPS (₹.) ⓘ | 4.8 | - |
| Reserves (₹ Cr.) ⓘ | -2 | - |
| P/BV ⓘ | 0.11 | - |
| PE ⓘ | 0.00 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 0.49 / 0.66 |
| All Time Low / High (₹) | 0.20 / 25.00 |
| Market Cap (₹ Cr.) | 0.2 |
| Equity (₹ Cr.) | 4.1 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 37.3 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Vardhaman Laboratories Limited was incorporated on April 24, 1985 under the Companies Act, 1956, in the State of Maharashtra as Vardhaman Laboratories Private Limited and subsequently converted into a Public Limited vide special Resolution dated October 15, 1993 and obtained a fresh certificate of Incorporation to change of name on December 7, 1993 as Vardhaman Laboratories Limited, from the registrar of Companies Maharashtra, Bombay.
At present the company is engaged in manufacturing varieties of formulations and marketing under the brand name of 'SAMRAT', gained sizable popularity in the area of Western Maharashtra and Southern part of India.
The company started its operation on a small scale basis and during this time was also in the process of identifying a viable project in the Pharmaceutical industry. After a thorough and exhaustive study, the project for manufacturing the Bulk Drugs as mentioned above was conceived in December 1993.
